![美国生物医学学会/[P28]氨甲酰化牛血清白蛋白（CBL-BSA）/0.5 mg/30P-CBL-BS105](https://www.ebiomall.cn/images/academybiomed/p28_300x300.jpg)
| Concentration: | 1 mg / ml, determined by the Lowry method |
| Source: | Bovine Serum Albumin was purchased from Boehringer Mannheim and was modified by carbamylation to form CBL modified BSA. |
| Buffer: | In 10 mM PBS, 0.15 M NaCl 0.5 mM EDTA, 0.01 % NaN3, pH 7.4. |
| Storage: | -20°C for short and long-term storage. Aliquot to avoid repeated freezing and thawing. |
*The products are for research or manufacturing use only, not for use in human therapeutic or diagnostic applications.
Importance
Carbamylation is a spontaneous nonenzymatic modification of proteins and amino acids by urea-derived isocyanate, which is generally present in human serum and is increased in uremic patients (Kraus and Kraus, 2001).
Proteins carbamylated at lysine or the terminal protein amino acids may play an important role in Chronic renal failure subjects in the development of atherosclerosis and cardiovascular diseases (Raine et al., 1991; Culleton et al., 1999).
Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214–9.
Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 2001; 78: S102–7.
Raine AE, MacMahon SH, Selwood NH, Wing AJ, Brunner FP. Mortality from myocardial infarction in patients on renal replacement therapy. Nephrol Dial Transplant 1991; 6: 902.
